Michael Rodamer
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Hepatotoxicity and Protection
-
- Tuberculosis Research and Epidemiology
Papers in
-
- Plant Toxicity and Pharmacological Properties 2
-
- Pharmacogenetics and Drug Metabolism 3
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Fritz Sörgel (6 shared papers)Uwe Fuhr (5 shared papers)Martina Kinzig (6 shared papers)Dorota Tomalik‐Scharte (4 shared papers)Alexander Jetter (3 shared papers)Martina Kinzig‐Schippers (2 shared papers)Bernhard Scheidel (1 shared paper)Oxana Doroshyenko (1 shared paper)
- Journals
- Journal of Chromatography B (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)European Journal of Clinical Pharmacology (2 papers)British Journal of Clinical Pharmacology (1 paper)PLoS ONE (1 paper)
- Partner nations
- GermanyAustraliaUnited States
In The Last Decade
Michael Rodamer
12 papers receiving 482 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 120
- Infectious Diseases 87
- Pharmacology 64
- Analytical Chemistry 33
- Oncology 82
Countries citing papers authored by Michael Rodamer
This map shows the geographic impact of Michael Rodamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rodamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rodamer more than expected).
Fields of papers citing papers by Michael Rodamer
This network shows the impact of papers produced by Michael Rodamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rodamer. The network helps show where Michael Rodamer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Rodamer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 157 | |
| 2 | 2004 | 52 | |
| 3 | 2010 | 43 | |
| 4 | 2015 | 41 | |
| 5 | 2011 | 40 | |
| 6 | 2015 | 38 | |
| 7 | 2009 | 34 | |
| 8 | 2011 | 33 | |
| 9 | 2009 | 19 | |
| 10 | 2020 | 19 | |
| 11 | 2008 | 10 | |
| 12 | Fast LC-MS quantification of ptesculentoside, caudatoside, ptaquiloside and corresponding pterosins in bracken ferns | 2020 | 8 |
About Michael Rodamer
Michael Rodamer is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Oncology and Epidemiology, having authored 12 papers that have together received 494 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Sesquiterpenes and Asteraceae Studies (2 papers), Pneumonia and Respiratory Infections (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Plant Toxicity and Pharmacological Properties (2 papers) and Chemotherapy-induced organ toxicity mitigation (1 paper). The work is most often cited by research in Pharmacology (120 citations), Infectious Diseases (87 citations), Pharmacology (64 citations), Analytical Chemistry (33 citations) and Oncology (82 citations). Michael Rodamer has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Fritz Sörgel, Uwe Fuhr, Martina Kinzig, Dorota Tomalik‐Scharte, Alexander Jetter, Martina Kinzig‐Schippers, Bernhard Scheidel, Oxana Doroshyenko, Ingolf Cascorbi and Paul W. Elsinghorst. Their work appears in journals such as Journal of Chromatography B, Antimicrobial Agents and Chemotherapy, European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.